Person

Robert W. Pangia

Formerly Director, Biogen

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$5.5M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • BIIB
    Biogen
    Director
    Jun 2016 – last filing Feb 2021

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Mar 18, 2019BIIBSale6,114$328.55$2.0M
Jan 9, 2018BIIBSale5,832$329.65$1.9M
Jan 9, 2017BIIBSale5,450$295.39$1.6M

SEC reporting-owner ID (CIK) 1236188 · all filings on EDGAR

Robert W. Pangia | USBoard